Organon (OGN) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
31 Jan, 2026Opening remarks and agenda
The meeting was held virtually to increase inclusivity and participation, with shareholders able to vote and ask questions online.
The agenda included introductions, formal business, and a Q&A session with the CEO.
All board members and executive officers were present, and the meeting was officially called to order at 9:05 A.M. EDT.
Board and executive committee updates
Ma. Fatima de Vera Francisco was recognized for her service, as she is not standing for re-election.
The board and committee chairs were introduced, including those for ESG, Audit, and Portfolio Development.
Shareholder proposals
Proposals included the election of four Class three directors, a non-binding advisory vote on executive compensation, and ratification of the independent auditor.
The board unanimously recommended voting in favor of all proposals.
Latest events from Organon
- 2025 revenue fell 3% to $6.2B; 2026 outlook is flat with margin and policy headwinds.OGN
Q4 202512 Feb 2026 - All board proposals passed, with 2024 revenue up 3% and a focus on cost and debt reduction.OGN
AGM 20253 Feb 2026 - Q2 revenue flat at $1.61B; guidance and cash flow targets reaffirmed despite margin declines.OGN
Q2 20242 Feb 2026 - Revenue down 7% in Q1 2025; guidance, deleveraging, and dividend reset reaffirmed.OGN
Q1 202519 Jan 2026 - 2024 revenue rose 3% ex-FX, with margin strength and Women's Health and biosimilar growth.OGN
Q4 202419 Jan 2026 - Q2 2025 revenue down 1%, guidance raised, leverage reduction and portfolio growth on track.OGN
Q2 202519 Jan 2026 - Q3 revenue up 4–5%, net income surged to $359M, and 2024 guidance was raised.OGN
Q3 202417 Jan 2026 - Growth in NEXPLANON and VTAMA offsets LOE headwinds, supporting margin and expansion plans.OGN
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Internal investigation resolved; focus shifts to cost discipline, growth, and portfolio optimization.OGN
Piper Sandler 37th Annual Healthcare Conference3 Dec 2025